Actively Recruiting

Phase Not Applicable
Age: 3Years - 50Years
All Genders
NCT06477263

NeuroCytotron in the Treatment of Autism Spectrum Disorder

Led by Neurocytonix, Inc. · Updated on 2025-02-06

100

Participants Needed

1

Research Sites

63 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Preliminary Efficacy and Feasibility of Using NeuroCytotron in the Treatment of Autism Spectrum Disorder

CONDITIONS

Official Title

NeuroCytotron in the Treatment of Autism Spectrum Disorder

Who Can Participate

Age: 3Years - 50Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female subjects with a confirmed diagnosis of ASD according to DSM-5 criteria
  • Age between 3 and 50 years
  • ASD severity grade 1 to 3 according to DSM-5 criteria
  • Informed consent provided by parents or legal representatives
  • Physically able and willing to participate in treatment sessions
  • Medically and psychologically stable for study participation
Not Eligible

You will not qualify if you...

  • Medical conditions contraindicating NeuroCytotron use, including severe neurological disorders
  • Uncontrolled epilepsy defined as more than 1 generalized seizure per month in the past 3 months
  • History of prolonged or repetitive seizures requiring rescue medication within 9 months
  • Participation in other autism therapies during the study
  • Logistical or situational issues preventing regular attendance
  • History of significant adverse reactions to similar treatments or anesthesia
  • Serious behavioral problems or aggression affecting safety
  • Current or recent (within 14 days) significant infection
  • Presence of magnetic implants, pacemakers, claustrophobia, or conditions preventing NeuroCytotron use

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

NeuroCytonix México

San Pedro Garza García, Nuevo León, Mexico, 66224

Actively Recruiting

Loading map...

Research Team

K

Karen Camarillo Cardenas

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here